Mamoru Naruse

This inventor holds 6 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 2 EPO patents. Top assignee: Teikoku Seiyaku Co., Ltd.. Active years: 2011-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mamoru Naruse. Retrieved from https://idiyas.com/inventor/mamoru-naruse

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 1)

% Patents Active = 83.3

CIPO Patents = 3

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 5(Granted Patents)

Location History:

Itano-gun, JP (2011)
Higashikagawa, JP (2017)
Awa, JP (2016 - 2018)
Tokushima, JP (2019)

Company Filing History:

6 out of 95

Teikoku Seiyaku Co., Ltd.

patents

Years Active: 2011-2019

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10376474 - Fentanyl-containing patch for external use (2019-08-13),

2. 10143662 - Fentanyl-containing adhesive preparation for external use (2018-12-04),

3. 9579297 - Pharmaceutical composition for application to nail (2017-02-28),

4. 9517211 - Fentanyl-containing patch for external use (2016-12-13),

5. 9375422 - Fentanyl-containing adhesive preparation for external use (2016-06-28),

6. 8029820 - Patches containing tulobuterol (2011-10-04),

Title: Mamoru Naruse: Innovator in Transdermal Drug Delivery Systems

Introduction

Mamoru Naruse is a prominent inventor based in Awa, Japan, known for his significant contributions to the field of transdermal drug delivery systems. With a total of six patents to his name, Naruse has focused on developing innovative solutions for effective medication administration.

Latest Patents

Naruse's latest patents include a fentanyl-containing patch for external use and a fentanyl-containing adhesive preparation for external use. The fentanyl patch features a laminate structure that enhances the permeation of fentanyl through the skin while ensuring storage stability and minimizing skin irritation. The adhesive preparation also demonstrates excellent skin permeation and high stability, preventing crystallization of fentanyl during storage.

Career Highlights

Naruse is currently associated with Teikoku Seiyaku Co., Ltd., a company renowned for its advancements in pharmaceutical technologies. His work has significantly impacted the development of effective transdermal systems, improving patient comfort and medication efficacy.

Collaborations

Some of Naruse's notable coworkers include Kenichi Hattori and Kunihiko Matsushita, who have collaborated with him on various projects within the company.

Conclusion

Mamoru Naruse's innovative work in transdermal drug delivery systems exemplifies the importance of advancements in medical technology. His contributions continue to enhance the effectiveness of pain management therapies.

Profile summary based on public USPTO records.